相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European Countries
Alexander C. J. van Akkooi et al.
ADVANCES IN THERAPY (2021)
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model
Emma H. A. Stahlie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo
Barbara Schwertner et al.
CANCERS (2021)
Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1
Hironari Nishizawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Jiyoung Lee et al.
NATURE (2019)
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Clotilde Wiel et al.
CELL (2019)
BACH1 Orchestrates Lung Cancer Metastasis (vol 178, pg 265, 2019)
Nicole M. Anderson et al.
CELL (2019)
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
Stephen J. Russell et al.
CANCER CELL (2018)
Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
Jacob P. van Vloten et al.
JOURNAL OF IMMUNOLOGY (2018)
PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins
Lili Li et al.
SCIENCE SIGNALING (2018)
PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins
Lili Li et al.
SCIENCE SIGNALING (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Role of Herpes Simplex Virus 1 γ34.5 in the Regulation of IRF3 Signaling
Richard Manivanh et al.
JOURNAL OF VIROLOGY (2017)
Local Delivery of OncoVEXmGM-CSF Generates Systemic AntitumorImmuneResponses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade
Achim K. Moesta et al.
CLINICAL CANCER RESEARCH (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Robert H. I. Andtbacka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer-fighting viruses win approval
Heidi Ledford
NATURE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
MiR-23a Facilitates the Replication of HSV-1 through the Suppression of Interferon Regulatory Factor 1
Jing Ru et al.
PLOS ONE (2014)
IFITM proteins - cellular inhibitors of viral entry
S. E. Smith et al.
CURRENT OPINION IN VIROLOGY (2014)
Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol
Su-Yang Liu et al.
IMMUNITY (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome
You Li et al.
ARCHIVES OF VIROLOGY (2011)
Comprehensive Characterization of Interaction Complexes of Herpes Simplex Virus Type 1 ICP22, UL3, UL4, and UL20.5
Junji Xing et al.
JOURNAL OF VIROLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Paola M. Barral et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The ties that bind a virus to the cell
Robert P. Kruger
CELL (2008)
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil et al.
NATURE (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Heme induces ubiquitination and degradation of the transcription factor bach1
Yukari Zenke-Kawasaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Bach1, a heme-dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure
Shusuke Hira et al.
IUBMB LIFE (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Transcriptional repression of human cad gene by hypoxia inducible factor-1 alpha
KF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1
H Suzuki et al.
EMBO JOURNAL (2004)
Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells mediated by the prostaglandin EP2 receptor
HS Sun et al.
ENDOCRINOLOGY (2003)
Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells
T Kitamuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
分享论文
